Iradimed Reports Strong Q1 Earnings and Introduces New Product
Iradimed (IRMD) stock surged over 4% following its first-quarter earnings report, outperforming the S&P 500. The company exceeded revenue and profit estimates, with revenue rising 13% to $21.9 million and net income increasing 24% to $5.8 million. The introduction of a new product and strong performance in MRI-compatible IV infusion pumps were key drivers.
Tickers: $IRMD
Topics: Earnings Medical Devices MRI Equipment Profitability Revenue Growth